Global Dermatophytic Onychomycosis Treatment Market Growth (Status and Outlook) 2023-2029

Global Dermatophytic Onychomycosis Treatment Market Growth (Status and Outlook) 2023-2029

Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.

LPI (LP Information)' newest research report, the “Dermatophytic Onychomycosis Treatment Industry Forecast” looks at past sales and reviews total world Dermatophytic Onychomycosis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Dermatophytic Onychomycosis Treatment sales for 2023 through 2029. With Dermatophytic Onychomycosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dermatophytic Onychomycosis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Dermatophytic Onychomycosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dermatophytic Onychomycosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dermatophytic Onychomycosis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dermatophytic Onychomycosis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dermatophytic Onychomycosis Treatment.

The global Dermatophytic Onychomycosis Treatment market size is projected to grow from US$ 1175 million in 2022 to US$ 1945.5 million in 2029; it is expected to grow at a CAGR of 7.5% from 2023 to 2029.

Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatophytic Onychomycosis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Systemic Therapy
Topical Therapy
Others

Segmentation by application
Hospitals
Dermatology Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bausch Health Companies
Novartis AG
Johnson and Johnson
Galderma S.A.
Celtic Pharmaceuticals
Anacor Pharmaceuticals
Moberg Pharma AB
GlaxoSmithKline
Pfizer Inc

Please note: The report will take approximately 2 business days to prepare and deliver.